CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 44.44%

Compliant submissions 4

Incompliant submissions 5

Total trials 9

My Organizations' Clinical Trials

Showing 150 of 430 entries

View as:

Behavioral Activation (BA) for Medication-responsive Chronically Depressed Patients With Impaired Social Functioning

Phase: N/A Priority: Normal

NCT ID: NCT01783080 Org: User:

Start: 06/30/10 End: 12/31/12 Due: 12/31/13

NT-814: Evaluation of Its Ability to Alter the Abuse Liability of Oxycodone in an Exploratory Clinical Study

Phase: N/A Priority: Normal

NCT ID: NCT02692157 Org: User:

Start: 02/29/16 End: 09/20/18 Due: 09/20/19

Open Label Trial of Rapastinel (Formerly GLYX-13) in Individuals With Obsessive-Compulsive Disorder

Phase: N/A Priority: Normal

NCT ID: NCT02267629 Org: User:

Start: 10/31/14 End: 02/29/16 Due: 02/28/17

Critical Time Intervention for Individuals With Hoarding Disorder

Phase: N/A Priority: Normal

NCT ID: NCT02367430 Org: User:

Start: 01/31/13 End: 07/31/15 Due: 07/31/16

Fluoxetine to Prevent Relapse and Enhance Psychological Recovery in Women With Anorexia Nervosa

Phase: N/A Priority: Normal

NCT ID: NCT00288574 Org: User:

Start: 01/31/00 End: 05/31/05 Due: 05/31/06

Combined Pharmacotherapy for Cannabis Dependency

Phase: N/A Priority: Normal

NCT ID: NCT01020019 Org: User:

Start: 01/31/10 End: 09/30/14 Due: 09/30/15

Glutamatergic Modulation of Motivation Enhancement: A Pilot Feasibility Trial

Phase: N/A Priority: Normal

NCT ID: NCT02373124 Org: User:

Start: 12/31/14 End: 10/31/16 Due: 10/31/17

Pilot Study of Ketamine in Adults With Obsessive-Compulsive Disorder (OCD)

Phase: N/A Priority: Normal

NCT ID: NCT01100255 Org: User:

Start: 04/30/10 End: 12/31/15 Due: 12/31/16

Glutamatergic Modulation of Cocaine-related Deficits

Phase: N/A Priority: Normal

NCT ID: NCT01790490 Org: User:

Start: 02/28/11 End: 03/31/12 Due: 03/31/13

Effect of Smoking Exposure on Smoking Relapse Following Brief Abstinence - 2

Phase: N/A Priority: Normal

NCT ID: NCT00136838 Org: User:

Start: 10/31/01 End: 06/30/06 Due: 06/30/07

Pilot Study of Vyvanse™ In ADHD Adolescents at Risk for Substance Abuse

Phase: N/A Priority: Normal

NCT ID: NCT00573534 Org: User:

Start: 03/31/08 End: 03/31/10 Due: 03/31/11

A Study of SPG Block for Opioid Withdrawal

Phase: N/A Priority: Normal

NCT ID: NCT04946656 Org: User:

Start: 02/03/23 End: 06/03/30 Due: 06/03/31

Gabapentin in Patients at Clinical Risk for Psychosis

Phase: N/A Priority: Normal

NCT ID: NCT02557945 Org: User:

Start: 08/01/15 End: 06/12/16 Due: 06/12/17

Ketamine in the Treatment of Suicidal Depression

Phase: N/A Priority: Normal

NCT ID: NCT01700829 Org: User:

Start: 06/30/12 End: 07/31/17 Due: 07/31/18

Nabilone in Cannabis Users With PTSD

Phase: N/A Priority: Normal

NCT ID: NCT03251326 Org: User:

Start: 10/31/15 End: 06/30/19 Due: 06/30/20

Prescription Opioid Effects in Abusers Versus Non-Abusers

Phase: N/A Priority: Normal

NCT ID: NCT00158184 Org: User:

Start: 06/30/04 End: 06/30/09 Due: 06/30/10

Effect of Memantine Versus Bupropion on Smoking Relapse in Nicotine-Dependent Individuals - 3

Phase: N/A Priority: Normal

NCT ID: NCT00136786 Org: User:

Start: 12/31/06 End: 05/31/09 Due: 05/31/10

Transcranial Magnetic Stimulation (TMS) and Obsessive Compulsive Disorder (OCD)

Phase: N/A Priority: Normal

NCT ID: NCT00106249 Org: User:

Start: 11/30/04 End: 01/31/14 Due: 01/31/15

A Clinical Trial of IPT-A to Prevent Suicide in Depressed Adolescents With Suicidal Behavior

Phase: N/A Priority: Normal

NCT ID: NCT01447602 Org: User:

Start: 09/30/11 End: 06/30/14 Due: 06/30/15

Overlapping Neural Circuits in Pediatric OCD

Phase: N/A Priority: Normal

NCT ID: NCT02421315 Org: User:

Start: 10/31/14 End: 09/30/21 Due: 09/30/22

A Study of L-DOPA for Depression and Slowing in Older Adults

Phase: N/A Priority: Normal

NCT ID: NCT02744391 Org: User:

Start: 08/24/16 End: 11/30/18 Due: 11/30/19

Surmounting Withdrawal to Initiate Fast Treatment With Naltrexone

Phase: N/A Priority: Normal

NCT ID: NCT04762537 Org: User:

Start: 03/16/21 End: 12/21/22 Due: 12/21/23

Food Exposure Therapy in Anorexia Nervosa

Phase: N/A Priority: Normal

NCT ID: NCT00755820 Org: User:

Start: 01/31/08 End: 01/31/12 Due: 01/31/13

Effects of Aripiprazole on Cocaine Craving and Self-Administration

Phase: N/A Priority: Normal

NCT ID: NCT00373880 Org: User:

Start: 04/30/05 End: 09/30/08 Due: 09/30/09

Testing an HIV Prevention Intervention for Psychiatric Patients in Brazil

Phase: N/A Priority: Normal

NCT ID: NCT00881699 Org: User:

Start: 09/30/06 End: 08/31/11 Due: 08/31/12

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
Behavioral Activation (BA) for Medication-responsive Chronically Depressed Patients With Impaired Social Functioning	NCT01783080	New York State Psychiatric Institute	user2@example.com	None	2010-06-30	2012-12-31	2013-12-31	-	-	2025-07-14
NT-814: Evaluation of Its Ability to Alter the Abuse Liability of Oxycodone in an Exploratory Clinical Study	NCT02692157	New York State Psychiatric Institute	user2@example.com	None	2016-02-29	2018-09-20	2019-09-20	-	-	2025-07-14
Open Label Trial of Rapastinel (Formerly GLYX-13) in Individuals With Obsessive-Compulsive Disorder	NCT02267629	New York State Psychiatric Institute	user2@example.com	None	2014-10-31	2016-02-29	2017-02-28	-	-	2025-07-14
Critical Time Intervention for Individuals With Hoarding Disorder	NCT02367430	New York State Psychiatric Institute	user2@example.com	None	2013-01-31	2015-07-31	2016-07-31	-	-	2025-07-14
Fluoxetine to Prevent Relapse and Enhance Psychological Recovery in Women With Anorexia Nervosa	NCT00288574	New York State Psychiatric Institute	user2@example.com	None	2000-01-31	2005-05-31	2006-05-31	-	-	2025-07-14
Combined Pharmacotherapy for Cannabis Dependency	NCT01020019	New York State Psychiatric Institute	user2@example.com	None	2010-01-31	2014-09-30	2015-09-30	-	-	2025-07-14
Glutamatergic Modulation of Motivation Enhancement: A Pilot Feasibility Trial	NCT02373124	New York State Psychiatric Institute	user2@example.com	None	2014-12-31	2016-10-31	2017-10-31	-	-	2025-07-14
Pilot Study of Ketamine in Adults With Obsessive-Compulsive Disorder (OCD)	NCT01100255	New York State Psychiatric Institute	user2@example.com	None	2010-04-30	2015-12-31	2016-12-31	-	-	2025-07-14
Glutamatergic Modulation of Cocaine-related Deficits	NCT01790490	New York State Psychiatric Institute	user2@example.com	None	2011-02-28	2012-03-31	2013-03-31	-	-	2025-07-14
Effect of Smoking Exposure on Smoking Relapse Following Brief Abstinence - 2	NCT00136838	New York State Psychiatric Institute	user2@example.com	None	2001-10-31	2006-06-30	2007-06-30	-	-	2025-07-14
Pilot Study of Vyvanse™ In ADHD Adolescents at Risk for Substance Abuse	NCT00573534	New York State Psychiatric Institute	user2@example.com	None	2008-03-31	2010-03-31	2011-03-31	-	-	2025-07-14
A Study of SPG Block for Opioid Withdrawal	NCT04946656	New York State Psychiatric Institute	user2@example.com	None	2023-02-03	2030-06-03	2031-06-03	-	-	2025-07-14
Gabapentin in Patients at Clinical Risk for Psychosis	NCT02557945	New York State Psychiatric Institute	user2@example.com	None	2015-08-01	2016-06-12	2017-06-12	-	-	2025-07-14
Ketamine in the Treatment of Suicidal Depression	NCT01700829	New York State Psychiatric Institute	user2@example.com	None	2012-06-30	2017-07-31	2018-07-31	-	-	2025-07-14
Nabilone in Cannabis Users With PTSD	NCT03251326	New York State Psychiatric Institute	user2@example.com	None	2015-10-31	2019-06-30	2020-06-30	-	-	2025-07-14
Prescription Opioid Effects in Abusers Versus Non-Abusers	NCT00158184	New York State Psychiatric Institute	user2@example.com	None	2004-06-30	2009-06-30	2010-06-30	-	-	2025-07-14
Effect of Memantine Versus Bupropion on Smoking Relapse in Nicotine-Dependent Individuals - 3	NCT00136786	New York State Psychiatric Institute	user2@example.com	None	2006-12-31	2009-05-31	2010-05-31	-	-	2025-07-14
Transcranial Magnetic Stimulation (TMS) and Obsessive Compulsive Disorder (OCD)	NCT00106249	New York State Psychiatric Institute	user2@example.com	None	2004-11-30	2014-01-31	2015-01-31	-	-	2025-07-14
A Clinical Trial of IPT-A to Prevent Suicide in Depressed Adolescents With Suicidal Behavior	NCT01447602	New York State Psychiatric Institute	user2@example.com	None	2011-09-30	2014-06-30	2015-06-30	-	-	2025-07-14
Overlapping Neural Circuits in Pediatric OCD	NCT02421315	New York State Psychiatric Institute	user2@example.com	None	2014-10-31	2021-09-30	2022-09-30	-	-	2025-07-14
A Study of L-DOPA for Depression and Slowing in Older Adults	NCT02744391	New York State Psychiatric Institute	user2@example.com	None	2016-08-24	2018-11-30	2019-11-30	-	-	2025-07-14
Surmounting Withdrawal to Initiate Fast Treatment With Naltrexone	NCT04762537	New York State Psychiatric Institute	user2@example.com	None	2021-03-16	2022-12-21	2023-12-21	-	-	2025-07-14
Food Exposure Therapy in Anorexia Nervosa	NCT00755820	New York State Psychiatric Institute	user2@example.com	None	2008-01-31	2012-01-31	2013-01-31	-	-	2025-07-14
Effects of Aripiprazole on Cocaine Craving and Self-Administration	NCT00373880	New York State Psychiatric Institute	user2@example.com	None	2005-04-30	2008-09-30	2009-09-30	-	-	2025-07-14
Testing an HIV Prevention Intervention for Psychiatric Patients in Brazil	NCT00881699	New York State Psychiatric Institute	user2@example.com	None	2006-09-30	2011-08-31	2012-08-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance